HAVCR2 and acute myeloid leukemia: Based on the previous finding of TOX expression concurrent with that of PD-1 and Tim-3 in T cells from patients with lymphoma (21), we analyzed the correlation of the gene expression level of the TOX genes and IC genes in AML patients (Figures 5A–C).